New patent for Stemline Therap drug ORSERDU

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for ORSERDU
Annual Drug Patent Expirations for ORSERDU

Orserdu is a drug marketed by Stemline Therap and is included in one NDA. It is available from one supplier. There are six patents protecting this drug.

This drug has thirty-two patent family members in nineteen countries.

The generic ingredient in ORSERDU is elacestrant dihydrochloride. One supplier is listed for this compound. Additional details are available on the elacestrant dihydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top